JCI - CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
Ecto-5′-Nucleotidase (CD73) Inhibits Nociception by Hydrolyzing AMP to Adenosine in Nociceptive Circuits | Journal of Neuroscience
Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients - eBioMedicine
CD73 Antikörper PE (ABIN1176840)
CD39/CD73: die kritischen Ziele für adenosinerge Signalwege - ACROBiosystems
Ecto‑5'‑nucleotidase (CD73) inhibits dorsal root ganglion neuronal apoptosis by promoting the Ado/cAMP/PKA/CREB pathway
Next-IO™ Anti-CD73 Therapeutic Monoclonal Antibody Program - Creative Biolabs
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation | Cancer Immunology, Immunotherapy
Frontiers | CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
CD39 and CD73 in immunity and inflammation: Trends in Molecular Medicine
Flow cytometry analysis of cell surface markers CD90, CD73, and CD105... | Download Scientific Diagram
Expression of stem cell markers in SHED: CD90, CD73, CD105, and... | Download Scientific Diagram
Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells | Scientific Reports
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies - ScienceDirect
CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression | Nature Communications
The cell-surface 5′-nucleotidase CD73 defines a functional T memory cell subset that declines with age - ScienceDirect
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents | Journal for ImmunoTherapy of Cancer
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma | World Journal of Surgical Oncology | Full Text
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers